School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

ImmuCell Corp ICCC

Healthcare · Biotechnology

$9.80last close 2026-10-09 · market cap $89.01M · delayed data

Trailing returns

1M-1.11%
3M-14.49%
6M+36.30%
1Y+45.83%
5Y+4.93%

Basis: Adjusted daily closes.

What it does

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E.

Open ICCC in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies